Compliance and Regulatory Matters Sample Clauses

Compliance and Regulatory Matters. 16.1 All licences, consents and other permissions and approvals required for or in connection with the carrying on of the business now being carried on by each member of the Group have been obtained and are in full force and effect and are listed in the Disclosure Letter. 16.2 All reports, returns and information required by law or as condition of any licence, consent, permission or approval to be made or given to any person or authority in connection with the business of any member of the Group have been made or given to the appropriate person or authority. 16.3 All products manufactured, tested, marketed, sold or distributed by each member of the Group are in compliance in all material respects with all applicable requirements of the relevant regulatory authority and all licences, permissions, authorisation or consents required for testing or placing the products on the market and any modifications to any product marketed by any member of the Group have been made in accordance with applicable laws and guidelines. 16.4 All preclinical and clinical trials conducted by each member of the Group have been conducted in full compliance with all applicable laws, regulations and requirements of the relevant competent authority and each member of the Group has obtained and maintained any necessary ethics committee approvals of clinical trials or modifications in respect of each clinical trial conducted by any member of the Group. In no clinical trial conducted by any member of the Group has ethics committee approval been suspended or withdrawn because of deficiencies attributed to a member of the Group. 16.5 Except as disclosed in the Disclosure Letter, no regulatory authority or notified body has served any notice, regulatory letter or similar communication on any member of the Group stating that the businesses were or are in breach of any law, regulation, approval, permission, authorisation, guidance or guideline or were or are the subject of any pending or anticipated regulatory investigation, review or inquiry or that there are circumstances currently existing which might reasonably be expected to lead to any loss of a refusal to renew any of the licences, consents, approvals, or authorisations held by any member of the Group. 16.6 Except as identified in the Disclosure Letter, no products marketed by any member of the Group have been recalled or subjected to regulatory authority correction and no member of the Group has received any order, demand or other for...
View Source
Compliance and Regulatory Matters a) CnG will immediately inform the Partner School of any changes to the accreditation status of the VET Program and the actions being taken to manage the transition or completion of students, as required. b) The Partner School will immediately inform CnG when it is not in compliance with this Agreement or the Skills Assure Supplier Third Party Arrangements Directive 2022-2024. c) The Partner School will take reasonable measures to ensure the safety and wellbeing of CnG’s trainers when on site, including being treated respectfully by staff and students. CnG agrees to comply with the Partners Schools directions made in respect of health and safety while on the site. CnG agrees that it and its trainers must conduct themselves in an appropriate manner behaving reasonably and respectfully. d) The Partner School will always have a registered teacher or authorised facilitator/staff member in attendance with the EHT, unless other regulatory compliant arrangements are agreed to by the Parties. e) CnG will ensure that it does not do anything which may cause the Partner School to be in breach of any applicable laws or to infringe on any third party’s rights. f) CnG must not do anything which does or may endanger the health and safety of any person or which does or may damage the reputation, viability or profitability of the school.
View Source
Compliance and Regulatory Matters. 1Each party shall comply and shall procure that each member of its Group complies with Applicable Laws applicable to it in connection with this Agreement (subject always to that party's obligations to comply with a Required Change due to a change in Applicable Laws as further described in the Change Management Procedure).
View Source
Compliance and Regulatory Matters. ▇▇▇ will agree to abide by all commercially reasonable informational barriers and other regulatory and compliance guidelines, policies and procedures established by First Security that would be relevant to consultants acting in their respective roles. Each of TIM’s professionals and analysts providing services under this Agreement will agree, upon request, to customary and commercially reasonable provisions regarding non-disclosure or use of confidential information, non-disparagement and non-solicitation of employees. Engagement Agreement with Triumph Investment Managers April 28, 2011 In the event that any banking regulator having jurisdiction over the Company or the Bank objects in writing to this Agreement, the Company and the Bank may immediately terminate ▇▇▇’s engagement hereunder, and, in such event, ▇▇▇ shall not under any circumstances be entitled to the payment of the Success Payment or the issuance of the Warrant upon the subsequent achievement of the Strategic Milestones or occurrence of an Alternative Transaction. Any termination of ▇▇▇’s engagement under this Agreement pursuant to the immediately preceding sentence shall not affect the Company’s obligations under this Agreement regarding indemnification and contribution, which provisions shall survive such termination and remain operative and in full force and effect.
View Source
Compliance and Regulatory Matters 
View SourceView Similar (5)

Related to Compliance and Regulatory Matters

  • Legal and Regulatory Compliance ‌ 4.22.1 During the term of this Contract, Contractor must comply with all local, state, and federal licensing, accreditation and registration requirements/standards, necessary for the performance of this Contract and all other applicable federal, state and local laws, rules, and regulations. 4.22.2 While on the HCA premises, Contractor must comply with HCA operations and process standards and policies (e.g., ethics, Internet / email usage, data, network and building security, harassment, as applicable). HCA will make an electronic copy of all such policies available to Contractor. 4.22.3 Failure to comply with any provisions of this section may result in Contract termination.

  • Clinical Data and Regulatory Compliance The preclinical tests and clinical trials, and other studies (collectively, “studies”) that are described in, or the results of which are referred to in, the Registration Statement or the Prospectus were and, if still pending, are being conducted in all material respects in accordance with the protocols, procedures and controls designed and approved for such studies and with standard medical and scientific research procedures; each description of the results of such studies is accurate and complete in all material respects and fairly presents the data derived from such studies, and the Company and its subsidiaries have no knowledge of any other studies the results of which are inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement or the Prospectus; the Company and its subsidiaries have made all such filings and obtained all such approvals as may be required by the Food and Drug Administration of the U.S. Department of Health and Human Services or any committee thereof or from any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board (collectively, the “Regulatory Agencies”); neither the Company nor any of its subsidiaries has received any notice of, or correspondence from, any Regulatory Agency requiring the termination, suspension or modification of any clinical trials that are described or referred to in the Registration Statement or the Prospectus; and the Company and its subsidiaries have each operated and currently are in compliance in all material respects with all applicable rules, regulations and policies of the Regulatory Agencies.

  • Tax and Regulatory Matters No Buyer Entity or, to the Knowledge of Buyer, any Affiliate thereof has taken or agreed to take any action, and Buyer does not have any Knowledge of any agreement, plan or other circumstance, that is reasonably likely to (i) prevent the Merger from qualifying as a “reorganization” within the meaning of Section 368(a) of the Internal Revenue Code, or (ii) materially impede or delay receipt of any of the Requisite Regulatory Approvals.

  • Statutory and Regulatory Compliance Contractor shall comply with all laws and regulations applicable to the Community Development Block Grant-Disaster Recovery funds appropriated by the Disaster Relief Appropriations Act, 2013 (Pub. L. 113-2), including but not limited to the applicable Office of Management and Budget Circulars, which may impact the administration of funds and/or set forth certain cost principles, including the allowability of certain expenses.

  • Compliance with Regulatory Requirements Upon demand by Lender, Borrower shall reimburse Lender for Lender’s additional costs and/or reductions in the amount of principal or interest received or receivable by Lender if at any time after the date of this Agreement any law, treaty or regulation or any change in any law, treaty or regulation or the interpretation thereof by any Governmental Authority charged with the administration thereof or any other authority having jurisdiction over Lender or the Loans, whether or not having the force of law, shall impose, modify or deem applicable any reserve and/or special deposit requirement against or in respect of assets held by or deposits in or for the account of the Loans by Lender or impose on Lender any other condition with respect to this Agreement or the Loans, the result of which is to either increase the cost to Lender of making or maintaining the Loans or to reduce the amount of principal or interest received or receivable by Lender with respect to such Loans. Said additional costs and/or reductions will be those which directly result from the imposition of such requirement or condition on the making or maintaining of such Loans.